tiprankstipranks
ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market
Holding SPRY?
Track your performance easily

ARS Pharmaceuticals (SPRY) Technical Analysis

320 Followers

Technical Sentiment

Overall Consensus
Strong Buy
16Bullish
2Neutral
4Bearish
Technical Analysis Consensus
Neutral
4Bullish
2Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
ARS Pharmaceuticals’s (SPRY) Moving Averages Convergence Divergence (MACD) indicator is 0.55, suggesting ARS Pharmaceuticals is a Sell.
ARS Pharmaceuticals’s (SPRY) 20-Day exponential moving average is 15.60, while ARS Pharmaceuticals’s (SPRY) share price is $16.61, making it a Buy.
ARS Pharmaceuticals’s (SPRY) 50-Day exponential moving average is 14.55, while ARS Pharmaceuticals’s (SPRY) share price is $16.61, making it a Buy.

ARS Pharmaceuticals (SPRY) Pivot Points

Nov 21, 2024, 10:41 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
15.00
15.42
16.23
16.65
17.46
17.88
18.69
Fibonacci
15.42
15.89
16.18
16.65
17.12
17.41
17.88
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

ARS Pharmaceuticals (SPRY) Moving Averages

Nov 21, 2024, 10:41 PM
Period
Simple
Exponential
MA5
16.34Buy
16.55Buy
MA10
15.63Buy
16.05Buy
MA20
15.75Buy
15.60Buy
MA50
14.39Buy
14.55Buy
MA100
12.67Buy
13.06Buy
MA200
10.62Buy
10.81Buy
ARS Pharmaceuticals’s (SPRY) 10-Day exponential moving average is 16.05, while ARS Pharmaceuticals’s (SPRY) share price is $16.61, making it a Buy.
ARS Pharmaceuticals’s (SPRY) 100-Day exponential moving average is 13.06, while ARS Pharmaceuticals’s (SPRY) share price is $16.61, making it a Buy.
ARS Pharmaceuticals’s (SPRY) stock price is $16.61 and ARS Pharmaceuticals’s (SPRY) 50-day simple moving average is 14.39, creating a Buy signal.
ARS Pharmaceuticals’s (SPRY) stock price is $16.61 and ARS Pharmaceuticals’s (SPRY) 100-day simple moving average is 12.67, creating a Buy signal.
ARS Pharmaceuticals’s (SPRY) stock price is $16.61 and ARS Pharmaceuticals’s (SPRY) 200-day simple moving average is 10.62, creating a Buy signal.

ARS Pharmaceuticals (SPRY) Technical Indicators

Nov 21, 2024, 10:41 PM
Name
Value
Implied Action
RSI (14)
68.58
Neutral
STOCH (9,6)
87.68
Sell
STOCHRSI (14)
81.33
Sell
MACD (12,26)
0.55
Sell
ADX (14)
18.23
Buy
Williams %R
-23.13
Buy
CCI (14)
194.80
Sell
ATR (14)
0.99
-
Ultimate Oscillator
54.08
Neutral
ROC
4.17
Buy
ARS Pharmaceuticals’s (SPRY) Relative Strength Index (RSI) is 68.58, creating a Neutral signal.
ARS Pharmaceuticals’s (SPRY) Trend Strength Indicator (ADX) is 18.23, creating a Buy signal.
ARS Pharmaceuticals’s (SPRY) Commodity Channel Index (CCI) is 194.80, creating a Sell signal.
ARS Pharmaceuticals’s (SPRY) Price Rate of Change (ROC) is 4.17, creating a Buy signal.

FAQ

Is SPRY a Buy, Hold, or Sell?
Based on SPRY’s technical indicators, SPRY is a Strong Buy.
    What is SPRY’s RSI (14)?
    SPRY’s RSI (14) is 68.58, which suggests SPRY is a Neutral.
      What is SPRY’s MACD?
      SPRY’s MACD is 0.55, which suggests SPRY is a Sell.
        What is SPRY’s 5-day moving average?
        SPRY’s 5-day moving average is 16.34, which suggests SPRY is a Buy.
          What is SPRY’s 20-day moving average?
          SPRY 20-day moving average is 15.75, which suggests SPRY is a Buy.
            What is SPRY’s 50-day moving average?
            SPRY’s 50-day moving average is 14.39, which suggests SPRY is a Buy.
              What is SPRY’s 200-day moving average?
              SPRY’s 200-day moving average is 10.62, which suggests SPRY is a Buy.
                What is SPRY’s Williams % R (14)?
                SPRY’s Williams % R (14) is -23.13, which suggests SPRY is a Buy.
                  What is SPRY’s CCI (14)?
                  SPRY’s CCI (14) is 194.80, which suggests SPRY is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis